Ene, C.-V.; Geavlete, B.; Mares, C.; Nicolae, I.; Ene, C.D.
Dynamic Soluble IL-6R/Soluble gp130 Ratio as a Potential Indicator for the Prostate Malignancy Phenotype—A Multicenter Case–Control Study. J. Pers. Med. 2024, 14, 1037.
https://doi.org/10.3390/jpm14101037
AMA Style
Ene C-V, Geavlete B, Mares C, Nicolae I, Ene CD.
Dynamic Soluble IL-6R/Soluble gp130 Ratio as a Potential Indicator for the Prostate Malignancy Phenotype—A Multicenter Case–Control Study. Journal of Personalized Medicine. 2024; 14(10):1037.
https://doi.org/10.3390/jpm14101037
Chicago/Turabian Style
Ene, Cosmin-Victor, Bogdan Geavlete, Cristian Mares, Ilinca Nicolae, and Corina Daniela Ene.
2024. "Dynamic Soluble IL-6R/Soluble gp130 Ratio as a Potential Indicator for the Prostate Malignancy Phenotype—A Multicenter Case–Control Study" Journal of Personalized Medicine 14, no. 10: 1037.
https://doi.org/10.3390/jpm14101037
APA Style
Ene, C.-V., Geavlete, B., Mares, C., Nicolae, I., & Ene, C. D.
(2024). Dynamic Soluble IL-6R/Soluble gp130 Ratio as a Potential Indicator for the Prostate Malignancy Phenotype—A Multicenter Case–Control Study. Journal of Personalized Medicine, 14(10), 1037.
https://doi.org/10.3390/jpm14101037